Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Central Nervous System dealmaking

2.1. Introduction
2.2. Central Nervous System partnering over the years
2.3. Central Nervous System partnering by deal type
2.4. Central Nervous System partnering by industry sector
2.5. Central Nervous System partnering by stage of development
2.6. Central Nervous System partnering by technology type
2.7. Central Nervous System partnering by therapeutic indication

Chapter 3 –Financial deal terms for Central Nervous System partnering

3.1. Introduction
3.2. Disclosed financials terms for Central Nervous System partnering
3.3. Central Nervous System partnering headline values
3.4. Central Nervous System deal upfront payments
3.5. Central Nervous System deal milestone payments
3.6. Central Nervous System royalty rates

Chapter 4 – Leading Central Nervous System deals and dealmakers

4.1. Introduction
4.2. Most active in Central Nervous System partnering
4.3. List of most active dealmakers in Central Nervous System
4.4. Top Central Nervous System deals by value

Chapter 5 – Central Nervous System contract document directory

5.1. Introduction
5.2. Central Nervous System partnering deals where contract document available

Chapter 6 – Central Nervous System dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Central Nervous System therapeutic target

Appendices

Appendix 1 – Directory of Central Nervous System deals by company A-Z 2014 to 2021
Appendix 2 – Directory of Central Nervous System deals by deal type 2014 to 2021
Appendix 3 – Directory of Central Nervous System deals by stage of development 2014 to 2021
Appendix 4 – Directory of Central Nervous System deals by technology type 2014 to 2021
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures

Figure 1: Central Nervous System partnering since 2014
Figure 2: Central Nervous System partnering by deal type since 2014
Figure 3: Central Nervous System partnering by industry sector since 2014
Figure 4: Central Nervous System partnering by stage of development since 2014
Figure 5: Central Nervous System partnering by technology type since 2014
Figure 6: Central Nervous System partnering by indication since 2014
Figure 7: Central Nervous System deals with a headline value
Figure 8: Central Nervous System deals with upfront payment values
Figure 9: Central Nervous System deals with milestone payment
Figure 10: Central Nervous System deals with royalty rates
Figure 11: Active Central Nervous System dealmaking activity– 2014 to 2021
Figure 12: Top Central Nervous System deals by value since 2014